Rayence Co (XKRX:228850) Debt-to-Equity : 0.02 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Rayence Co Debt-to-Equity?

Rayence Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩3,003 Mil. Rayence Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩2,842 Mil. Rayence Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩242,839 Mil. Rayence Co's debt to equity for the quarter that ended in Mar. 2024 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Rayence Co's Debt-to-Equity or its related term are showing as below:

XKRX:228850' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.04 Max: 0.33
Current: 0.02

During the past 10 years, the highest Debt-to-Equity Ratio of Rayence Co was 0.33. The lowest was 0.01. And the median was 0.04.

XKRX:228850's Debt-to-Equity is ranked better than
91.99% of 699 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs XKRX:228850: 0.02

Rayence Co Debt-to-Equity Historical Data

The historical data trend for Rayence Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rayence Co Debt-to-Equity Chart

Rayence Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.08

0.09

0.08

0.02

Rayence Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.01	0.01	0.02	0.02	0.02

Competitive Comparison of Rayence Co's Debt-to-Equity

For the Medical Devices subindustry, Rayence Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rayence Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rayence Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Rayence Co's Debt-to-Equity falls into.

Rayence Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Rayence Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2697.854	+	1147.621)	/	240221.445
	=	0.02

Rayence Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3002.513	+	2841.603)	/	242839.467
	=	0.02

Rayence Co (XKRX:228850) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Rayence Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Rayence Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Rayence Co (XKRX:228850) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rayence Co Ltd (XKRX:228850) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

14 Samsung 1-ro 1-gil, Gyeonggi-do, Hwaseong, KOR, 18449

Website

http://www.rayence.com

Rayence Co Ltd is engaged in providing dental, medical, veterinary, and industrial X-ray detector products. It also has the techniques for designing products such as CMOS Wafer, developing flat panel detectors (TFT), and using the core technology of scintillator, which is used for radiation detection. TFT based detectors have diagnostic imaging capabilities with a high grey scale range. CMOS products provide both static and dynamic imaging capabilities and are produced utilizing ASIC design.

Rayence Co (XKRX:228850) Headlines

No Headlines